Previous 10 | Next 10 |
2024-04-30 11:30:18 ET Summary Sanofi beat Q1 earnings estimates with revenue at $11.36 billion and EPS at 97 cents, driven largely by Dupixent. Key drugs like Nexviazyme and Altuviiio showed strong performance, with the former doubling its revenue. Despite a high profitabilit...
2024-04-28 22:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-26 14:32:03 ET More on Bristol, Sanofi, Takeda Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript Sanofi 2024 Q1 - Results - Earnings Call Presentation Takeda s...
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
2024-04-25 11:24:10 ET Sanofi (SNY) Q1 2024 Earnings Conference Call April 25, 2024 08:30 AM ET Company Participants Paul Hudson - Chief Executive Officer François-Xavier Roger - Chief Financial Officer Houman Ashrafian - Executive Vice President & Head-...
2024-04-25 11:24:05 ET More on AbbVie AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie: Through Humira's Crisis Towards Solid Growth AbbVie: Great To Be Proven Wrong - Still Not A Buy AbbVie Q1 Preview: Skyrizi and Rinvoq’s...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-25 01:38:35 ET More on Sanofi: Sanofi: My Top Pick In Big Pharma Sanofi reportedly lining up banks for consumer products spinoff Sanofi succeeds in late-stage trial for blood disorder candidate Read the full article on Seeking Alpha For furthe...
2024-04-23 13:32:13 ET More on Sanofi Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi succeeds in late-stage trial for ...
2024-04-23 13:21:30 ET More on Alto Neuroscience Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders Stifel, Baird, Jefferies bullish on Alto Neuroscience, cite upcoming data Alto Neuroscience stock rallies 35% following upsized IPO ...
News, Short Squeeze, Breakout and More Instantly...
2024-05-19 08:49:00 ET Vaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business might sink soon -- Novavax reported positive developments in its latest quarterly update that...
2024-05-18 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...